Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Classical hematology 1

Conditions

Carcinoma, Non-Small-Cell Lung 15Breast Neoplasms 14Sarcoma 11Squamous Cell Carcinoma of Head and Neck 10Glioblastoma 10Esophageal Neoplasms 9Rectal Neoplasms 8Stomach Neoplasms 7Urinary Bladder Neoplasms 6Neoplasms 6Carcinoma, Hepatocellular 6Pancreatic Neoplasms 5Colorectal Neoplasms 5Brain Neoplasms 5Oropharyngeal Neoplasms 4Lung Neoplasms 4Hypopharyngeal Neoplasms 4Head and Neck Neoplasms 4Glioma 4Recurrence 3Prostatic Neoplasms 3Parkinson Disease 4, Autosomal Dominant Lewy Body 3Neoplasm Metastasis 3Mouth Neoplasms 3Melanoma 3Colonic Neoplasms 3Astrocytoma 3Triple Negative Breast Neoplasms 2Thyroid Neoplasms 2Skin Neoplasms 2

Interventions

Surgical Procedures, Operative 1S-Adenosylmethionine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hepatic Veno-Occlusive Disease × Surgical Procedures, Operative × 1 year × Clear all
NCT06258525 2026-05-06

SAMe in Prevention of Oxaliplatin-associated Liver Injury

Cedars-Sinai Medical Center

Phase 2 Not yet recruiting
30 enrolled
Classical hematologyGastrointestinal

Hepatic Veno-Occlusive Disease, Colorectal Neoplasms, Chemical and Drug Induced Liver Injury

Data powered by HemOnc (CC BY 4.0) Colophon âš¡